Unknown

Dataset Information

Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes.


ABSTRACT:

Importance

Nearly 30% of individuals with gestational diabetes (GDM) do not achieve glycemic control with lifestyle modification alone and require medication treatment. Oral agents, such as glyburide, have several advantages over insulin for the treatment of GDM, including greater patient acceptance; however, the effectiveness of glyburide for the treatment of GDM remains controversial.

Objective

To compare the perinatal and neonatal outcomes associated with glyburide vs insulin using causal inference methods in a clinical setting with information on glycemic control.

Design, setting, and participants

The population-based cohort study included patients with GDM who required medication treatment from 2007 to 2017 in Kaiser Permanente Northern California. Machine learni

SUBMITTER: Hedderson MM 

PROVIDER: S-EPMC8972026 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature